169 related articles for article (PubMed ID: 19285155)
21. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
[TBL] [Abstract][Full Text] [Related]
22. B cell depletion reduces the development of atherosclerosis in mice.
Ait-Oufella H; Herbin O; Bouaziz JD; Binder CJ; Uyttenhove C; Laurans L; Taleb S; Van Vré E; Esposito B; Vilar J; Sirvent J; Van Snick J; Tedgui A; Tedder TF; Mallat Z
J Exp Med; 2010 Aug; 207(8):1579-87. PubMed ID: 20603314
[TBL] [Abstract][Full Text] [Related]
23. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
Frostegård J
Clin Immunol; 2010 Jan; 134(1):47-54. PubMed ID: 19748321
[TBL] [Abstract][Full Text] [Related]
24. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.
Caligiuri G; Nicoletti A; Poirier B; Hansson GK
J Clin Invest; 2002 Mar; 109(6):745-53. PubMed ID: 11901183
[TBL] [Abstract][Full Text] [Related]
25. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
26. Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies.
Porsch F; Mallat Z; Binder CJ
Cardiovasc Res; 2021 Nov; 117(13):2544-2562. PubMed ID: 34450620
[TBL] [Abstract][Full Text] [Related]
27. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
[TBL] [Abstract][Full Text] [Related]
28. Circulating oxidized LDL: a biomarker and a pathogenic factor.
Ishigaki Y; Oka Y; Katagiri H
Curr Opin Lipidol; 2009 Oct; 20(5):363-9. PubMed ID: 19625960
[TBL] [Abstract][Full Text] [Related]
29. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530
[TBL] [Abstract][Full Text] [Related]
30. Antibodies against oxidized low-density lipoprotein for the treatment of vulnerable plaques.
Nilsson J; Glazer S; Carlsson R
Curr Opin Investig Drugs; 2006 Sep; 7(9):815-9. PubMed ID: 17002259
[TBL] [Abstract][Full Text] [Related]
31. Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine.
Nguyen JT; Myers N; Palaia J; Georgopoulos A; Rubins JB; Janoff EN
Transl Res; 2007 Sep; 150(3):172-9. PubMed ID: 17761370
[TBL] [Abstract][Full Text] [Related]
32. Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells.
Hammad SM; Taha TA; Nareika A; Johnson KR; Lopes-Virella MF; Obeid LM
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):126-40. PubMed ID: 16516816
[TBL] [Abstract][Full Text] [Related]
33. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
Phillips NE; Gravel KA; Tumas K; Parker DC
J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
[TBL] [Abstract][Full Text] [Related]
34. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies.
Klaus GG; Bijsterbosch MK; Parkhouse RM
Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
36. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.
Sekigawa I; Okada T; Noguchi K; Ueda G; Hirose S; Sato H; Shirai T
J Immunol; 1987 May; 138(9):2890-5. PubMed ID: 2952727
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
Hulthe J
Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729
[TBL] [Abstract][Full Text] [Related]
38. Activation and proliferation signals in mouse B cells. III. Intact (IGG) anti-immunoglobulin antibodies activate B cells but inhibit induction of DNA synthesis.
Klaus GG; Hawrylowicz CM; Holman M; Keeler KD
Immunology; 1984 Dec; 53(4):693-701. PubMed ID: 6334018
[TBL] [Abstract][Full Text] [Related]
39. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.
Smook ML; van Leeuwen M; Heeringa P; Damoiseaux JG; Theunissen R; Daemen MJ; Lutgens E; Tervaert JW
Clin Exp Immunol; 2008 Nov; 154(2):264-9. PubMed ID: 18778362
[TBL] [Abstract][Full Text] [Related]
40. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
